z-logo
open-access-imgOpen Access
Cost Effectiveness Analysis Of Gefitinib Plus Chemotherapy Versus Gefitinib Alone For Advanced Non-Small-Cell Lung Cancer With EGFR Mutations In China
Author(s) -
Bairong Shen,
Li Chen,
J. Javier Meana
Publication year - 2021
Publication title -
proceedings of mol2net'21, conference on molecular, biomedical and computational sciences and engineering, 7th ed.
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/mol2net-07-11615
Subject(s) - gefitinib , lung cancer , oncology , chemotherapy , medicine , epidermal growth factor receptor , cancer research , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom